Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM5 | P08912 | 1/20 | 0.54 |
| ▸ | CHKA | P35790 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | HBB | P68871 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.41 |
| ▸ | DHFR | P00374 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.38 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3409151 | 0.87 | CHRM5 (0.68) | CHRM5CHKAALDH1A1TSHRMAPT | |
| SCHEMBL517128 | 0.84 | ALDH1A1 (0.67) | ALDH1A1TSHRMAPTSMN1; SMN2ALOX15 | |
| SCHEMBL22083898 | 0.84 | ALDH1A1 (0.67) | ALDH1A1TSHRMAPTSMN1; SMN2ALOX15 | |
| SCHEMBL15854781 | 0.84 | ALDH1A1 (0.67) | ALDH1A1TSHRMAPTSMN1; SMN2ALOX15 | |
| SCHEMBL812498 | 0.84 | ALDH1A1 (0.67) | ALDH1A1TSHRMAPTSMN1; SMN2ALOX15 | |
| SCHEMBL12593354 | 0.83 | CHRM5 (0.50) | CHRM5CHKAALDH1A1TSHRMAPT | |
| SCHEMBL13367579 | 0.82 | CHRM5 (0.50) | CHRM5CHKAALDH1A1TSHRMAPT | |
| SCHEMBL177904 | 0.79 | MAPT (0.52) | CHRM5CHKAALDH1A1TSHRMAPT | |
| SCHEMBL20628911 | 0.79 | CHRM5 (0.46) | CHRM5CHKAALDH1A1TSHRMAPT | |
| SCHEMBL2222390 | 0.79 | CHKA (0.52) | CHRM5CHKAALDH1A1MAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11706938-B2 | Photoelectric conversion element and photoelectric conversion module | RICOH COMPANY, LTD. (JP) | 2023-07-18 | — | — | US | disclosed |
| US-11706938-B2 | Photoelectric conversion element and photoelectric conversion module | RICOH COMPANY, LTD. (JP) | 2023-07-18 | — | — | US | disclosed |
| US-20220392714-A1 | PHOTOELECTRIC CONVERSION ELEMENT, PHOTOELECTRIC CONVERSION MODULE, ELECTRONIC DEVICE, AND POWER SUPPLY MODULE | RICOH COMPANY, LTD. (JP) | 2022-12-08 | — | — | US | disclosed |
| US-20210280809-A1 | PHOTOELECTRIC CONVERSION ELEMENT AND PHOTOELECTRIC CONVERSION MODULE | RICOH COMPANY, LTD. (JP) | 2021-09-09 | — | — | US | disclosed |
| US-20210013412-A1 | PHOTOELECTRIC CONVERSION ELEMENT AND PHOTOELECTRIC CONVERSION ELEMENT MODULE | RICOH COMPANY, LTD. (JP) | 2021-01-14 | — | — | US | disclosed |
| US-20200273630-A1 | PHOTOELECTRIC CONVERSION ELEMENT AND SOLAR CELL | TANAKA YUUJI (JP) | 2020-08-27 | — | — | US | disclosed |
| US-10636579-B2 | Photoelectric conversion element and solar cell | RICOH COMPANY, LTD. (JP) | 2020-04-28 | — | — | US | disclosed |
| US-20170069431-A1 | PHOTOELECTRIC CONVERSION ELEMENT AND SOLAR CELL | RICOH COMPANY, LTD. (JP) | 2017-03-09 | — | — | US | disclosed |
| US-20170069431-A1 | PHOTOELECTRIC CONVERSION ELEMENT AND SOLAR CELL | RICOH COMPANY, LTD. (JP) | 2017-03-09 | — | — | US | disclosed |
| US-20120129893-A1 | Inhibition Of Raf Kinase Using Substituted Heterocyclic Ureas | DUMAS JACQUES (US) | 2012-05-24 | — | — | US | disclosed |
| US-20120129893-A1 | Inhibition Of Raf Kinase Using Substituted Heterocyclic Ureas | DUMAS JACQUES (US) | 2012-05-24 | — | — | US | disclosed |
| US-20070244120-A1 | INHIBITION OF RAF KINASE USING SUBSTITUTED HETEROCYCLIC UREAS | BAYER HEALTHCARE LLC | 2007-10-18 | — | — | US | disclosed |
| US-20070244120-A1 | INHIBITION OF RAF KINASE USING SUBSTITUTED HETEROCYCLIC UREAS | BAYER HEALTHCARE LLC | 2007-10-18 | — | — | US | disclosed |
| US-20070142369-A1 | Combination of an H3 antagonist/inverse agonist and an appetite suppressant | SCHERING CORPORATION | 2007-06-21 | — | — | US | disclosed |
| US-7220735-B2 | Benzimidazolone histamine H3 antagonists | SCHERING CORPORATION (US) | 2007-05-22 | — | — | US | disclosed |
| US-20060058357-A1 | Delta2-1,2,3-triazoline anticonvulsants and their active metabolite analogues, the aminoalkylpyridines, are excitatory amino acid antagonists and antiischemic agents, useful in the treatment of cerebral ischemia resulting from stroke | K AND K BIOSCIENCE, INC. (US) | 2006-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070142369-A1 | Combination of an H3 antagonist/inverse agonist and an appetite suppressant | CNR2, GPR119, GLP1R | CHRM5 312/4885CHKA 469/4885ALDH1A1 3184/4885 |
| US-20060058357-A1 | Delta2-1,2,3-triazoline anticonvulsants and their active metabolite analogues, the aminoalkylpyridines, are excitatory amino acid antagonists and antiischemic agents, useful in the treatment of cerebral ischemia resulting from stroke | SIGMAR1, GRM1, GRIN2C | CHRM5 96/4885CHKA 407/4885ALDH1A1 1891/4885 |
| US-20070244120-A1 | INHIBITION OF RAF KINASE USING SUBSTITUTED HETEROCYCLIC UREAS | BRAF, RAF1, ARAF | CHRM5 4885/4885CHKA 288/4885ALDH1A1 2759/4885 |
| US-20120129893-A1 | Inhibition Of Raf Kinase Using Substituted Heterocyclic Ureas | BRAF, RAF1, ARAF | CHRM5 4885/4885CHKA 288/4885ALDH1A1 2759/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.